A Study of LY3471851 in Participants With Eczema

NCT04081350 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Dermatitis, Atopic

Interventions

DRUG: LY3471851
DRUG: Placebo

Sponsor

Nektar Therapeutics

Collaborators

[object Object]